
Aubagio
Brand for: Teriflunomide
My Prescription
Payment
Select pharmacy




$23.50
Print or send this coupon to your phone
About Aubagio
Drug Details
Teriflunomide, marketed as Aubagio, is a prescribed medication for adults with relapsing forms of multiple sclerosis (MS). This drug is not a cure, but it helps manage the condition by reducing certain immune cells that mistakenly attack the nervous system, particularly the brain and spinal cord. By doing so, it decreases the frequency of flare-ups and may slow the progression of physical disabilities caused by MS. Taken orally once a day, Teriflunomide provides a convenient treatment option. However, users might experience side effects such as headaches, diarrhea, and hair thinning. Always consult with your healthcare provider before starting any new medication to ensure it is appropriate for your specific health needs.
Aubagio (Teriflunomide) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 7MG | 28 Tablets | $25.89 | $0.93 |
| 7MG | 30 Tablets | $26.53 | $0.88 |
| 14MG | 30 Tablets | $23.62 | $0.79 |
| 14MG | 28 Tablets | $23.18 | $0.83 |
Aubagio FAQs
The cost of Aubagio can vary significantly depending on factors such as insurance coverage, pharmacy, and location. Without insurance, the price can be quite high, often exceeding several thousand dollars per month. Patients are encouraged to check with their insurance provider for specific coverage details and to explore any available patient assistance programs that may help reduce the cost.
Aubagio (teriflunomide) is considered an effective treatment option for relapsing forms of multiple sclerosis (MS). Clinical studies have shown that it can reduce the frequency of relapses and slow the progression of physical disability. However, the effectiveness can vary among individuals, and it is important for patients to discuss with their healthcare provider whether Aubagio is the right treatment for their specific condition.
Yes, Aubagio (teriflunomide) is considered an immunomodulatory drug with immunosuppressive properties. It is used to treat relapsing forms of multiple sclerosis by reducing the activity of the immune system.
Aubagio should not be taken by individuals with severe liver impairment, those who are pregnant or planning to become pregnant, and individuals with a known hypersensitivity to teriflunomide or any of the drug's components. Additionally, it is not recommended for individuals with severe immunodeficiency states, bone marrow disease, or serious infections. It is important for patients to discuss their full medical history with their healthcare provider before starting Aubagio.
Yes, teriflunomide is considered an immunomodulatory drug with immunosuppressive properties. It is used primarily in the management of multiple sclerosis to help reduce the frequency of relapses.